晚期实体瘤患者皮下注射与静脉注射抗PD

SCI

4June

AssessmentofSubcutaneousvsIntravenousAdministrationofAnti–PD-1AntibodyPF-inPatientsWithAdvancedSolidTumors

JohnsonML,BraitehF,Grilley-OlsonJE,etal.AssessmentofSubcutaneousvsIntravenousAdministrationofAnti-PD-1AntibodyPF-inPatientsWithAdvancedSolidTumors:APhase1Dose-EscalationTrial.JAMAOncol.

CorrespondingAuthor:MelissaL.Johnson,MD,SarahCannonResearchInstitute,TennesseeOncologyPLLC,thAveN,Ste,Nashville,TN(johnson

转载请注明：http://www.gwoao.com/jbzd/33897.html